effect in promoting neuronal regeneration via in vitro and in vivo TBI models. Intranasal 48 administration of WNT3A protein to TBI mice increased NeuN + cells compared to 49 control mice as well as retained motor function based on behavior analysis. Since TBI 50 is known to reprogram the epigenome, chromatin immunoprecipitation-sequencing of 51 histone H3K27ac and H3K4me3 was performed to address the transcriptional 52 regulation of WNT3A during neuronal regeneration. We predicted, characterized and 53
proposed that a histone H3K4me1-marked enhancer may undergo topological 54 transformation to regulate the WNT3A gene expression. 55 6 mg/kg body-weight/rat) was intraperitoneally injected to mitigate the pain. Abdominal 155 incision was performed to expose the E18 embryos. Following embryos take-away, 156 female rats were scarified via cutting through the diagram. Primary cortical neurons 157 were dissociated from dissected cortices of rat embryos (E18) as previously described 158 (Chen et al. 2015; Shih et al. 2013 ). Cells were seeded on PLL-coated plates. On day 159 in vitro (DIV) 0, primary neurons were cultured in MEM supplemented with 5% FBS, 160 5% HS, and 0.5 mg/ml PS under 5% CO2 condition. Culture medium was changed to 161 Neurobasal ® medium containing 25 μM glutamate, 2% B-27™ supplement, 0.5 mM L-162
Gln, and 50 units/ml AA on DIV1. AraC (10 μM) was added to neurons on DIV2 to 163 inhibit proliferation of glial cells. On DIV3, medium was changed to Neurobasal ® 164 medium containing 2% B-27™ supplement, 0.5 mM L-Gln and 50 units/ml AA. After 165 DIV3, half the medium was exchanged with fresh Neurobasal/Glutamine medium 166 every 3 days. 167
For the injury assay, primary neurons were seeded on PLL-coated wells. On DIV8, 168 neurons were injured by scraping with a p20 tip to generate two injured gaps in each 169 well ( Fig. 1a ). For samples with WNT recombinant protein treatments, cortical neurons 170 were pre-treated with WNT3A (50 ng/ml), WNT8A (100 ng/ml), WNT9B (100 ng/ml), 171 or phosphate buffered saline (PBS) control 1 h prior to injury. For treatment with WNT 172 inhibitor IWR-1, cortical neurons were treated with IWR-1 (10 µM) or DMSO control 173 (1%) immediately after injury. Neurite re-growth was monitored from iDIV8 to iDIV11 174 in the same field-of-view by using the "Mark and Find" positioning function of 175 AxioVision software (Zeiss). Live images were captured on a Carl Zeiss Observer Z1 176 microscope. The average width of injured gaps was calculated from measurements 177 made at twelve positions in each gap. The remaining gap distance was measured at the 178 indicated time points. The percentage of gap closure was calculated as 100% × (1 -179 remaining gap distance/original gap distance). Up to six injured gaps were quantified 180 per condition in at least three independent experiments. 181
To track re-growth of individual neurons, the tracking function of AxioVision 182 software (Zeiss) was used on live images from the injury assay. From iDIV8 to iDIV11, 183 the re-growth of 12 single neurites per field was tracked in three injured gaps in three 184 independent experiments. The tips of regenerating neurites were located at 24-h 185 intervals after injury, and the length of extension was measured for each day. The 186 average length of neurite re-growth per day and the average cumulative re-growth ( 0-187 10 and DIV10 with 0.8% formaldehyde. Chromatin was sonicated to generate 200-500 bp 287 fragments for subsequent immunoprecipitation of histone-DNA complexes using anti-288
H3K4me3, anti-H3K4me1, or anti-rabbit IgG antibody-conjugated protein A. Final 289
DNA purification was carried out by RNase A and Proteinase K treatments, followed 290 by phenol/chloroform DNA extraction. The immunoprecipitated DNA and input control 291 were analyzed by qPCR using Power SYBR Green Master Mix and an ABI 292
StepOnePlus Real-Time PCR System. Specific primers were designed to amplify 293 WNT3A, WNT9B and WNT10A promoter regions and putative enhancers e5, e7 and e10. 294
For qPCR quantification, total RNA or ChIP DNA were prepared from primary 295 cortical neurons at indicated time points and analyzed by qPCR using Power SYBR 296
Green Master Mix and an ABI StepOnePlus Real-Time PCR System. For gene 297 expression analysis, total RNA from neurons was isolated by TRIzol reagent following 298 the manufacturer's instructions and processed with a High-Capacity cDNA Reverse 299 Transcription Kit (Cat#4368814; Applied Biosystems) before qPCR. Relative gene 300 expression was calculated by the ddCt method, normalized to GAPDH. For the ChIP 301 assay, immunoprecipitated DNA and input control were prepared as described above. 302
The enrichment of histone modification at promoters or enhancers was determined as 303 percentage of input (% input) = 100 × 2^{Ct(ChIP) -[Ct(input) -log2(input dilution 304 factor)]}. Input dilution factor = 1/(fraction of the input chromatin saved). 305
For eRNA quantification, total RNA was isolated for reverse transcription 306 polymerase chain reaction (RT-PCR) assays. eRNAs of interest were amplified by 307 specific primers and analyzed by DNA electrophoresis. Band intensities were 308 quantified by GelPro31 software and normalized to GAPDH. 309 310 2.7 Organotypic brain slice culture 311
Brains isolated from E18 rats were washed with HBSS medium and embedded in 2.5% 312 low-melting agarose gel. The brain was then soaked in the artificial cerebrospinal fluid 313 (ACSF: 125 mM NaCl, 5 mM KCl, 1.25 mM NaH2PO4, 1 mM MgSO4, 2 mM CaCl2, 314 25 mM NaHCO3 and 20 mM glucose; pH 7.4) pre-pumped with 95% O2/5% CO2 and 315 sectioned by a Leica microtome VT100. Coronal tissue sections with a thickness of 350 316 µm were collected and injured with a scalpel as indicated. Sliced tissues were cultured 317 on PLL-coated inserts in 66% BME medium supplemented with 25% HBSS, 5% FBS, 318 1% N-2 Supplement, 1% P/S, and 0.66% (wt/vol) D-(+)-glucose. For WNT3A 319 11 treatment, WNT3A recombinant protein (50 ng/ml) was added daily, along with fresh 320 culture medium. AraC (5 μM) was administered from DIV0 to DIV2 to limit the 321 proliferation of glial cells. 322
For immunofluorescence staining of brain slices, injured brain slices were fixed 323 with 4% PFA for 2 h at room temperature on iDIV4. The insert membrane with the 324 brain slice attached was trimmed and tissues were subjected to immunostaining of anti-325 TUJ1 and anti-GFAP antibodies at dilutions of 1:750 and 1:500 respectively overnight 326 at 4°C and1:1000 secondary antibodies overnight at 4°C. DAPI was used to stain the 327 nuclei at room temperature for 2 h. The brain slices were mounted and images were 328 taken with a Carl Zeiss LSM780 confocal microscope. For quantification of 329 regenerating injured brain slice, the area that contained of regenerating neurites and the 330 length of injured tissue border were measured by Zeiss ZEN 2.3 lite Imaging Software. 331
The length of regenerating neurites was calculated as (area/length). 332 333
Controlled cortical injury (CCI) model 334
Eight-to-ten-week old C57BL/6J male mice were purchased from National Laboratory 335
Animal Center, Taiwan, and subjected to TBI by using the pneumatic CCI equipment 336 (Electric Cortical Contusion Impactor, Custom Design & Fabrication, Inc., the United 337 States). Inhalation anesthesia was performed with 3-5% isoflurane and maintained 338 anesthetic of the mice with 1.5-3% isoflurane. Buprenorphine (0.2 mg/100 g body-339 weight/mouse) was intraperitoneally injected to mitigate the pain. Upon anesthesia, the 340 mouse was fastened on the stereotaxic frame. Craniectomy was then performed to 341 remove the skull in a shape of 3-mm-diameter circle over left frontoparietal cortex (−0.5 342 mm anteroposterior and +0.5 mm mediolateral to bregma). After exposing the dura 343 matter, the brain was impacted by pneumatically operated CCI device at the velocity of 344 3 m/s, reaching 1 mm in depth, affecting a 2-fmm-diameter circular area, and with 500-345 ms dwell time to generate mild TBI (Yu et al. 2009 ). After CCI-induced brain injury 346 and suturing, PBS or 50 ng WNT3A was intranasally delivered to mice daily for 347 consecutively four days. On 4 dpi, the TBI mice were anesthetized and perfused with 348 saline and 4% paraformaldehyde. The brain tissues were then isolated, immersed in 349 10%, 15%, 20% sucrose followed by embedded in Shandon Cryomatrix embedding 350 resin (Cat#6769006; Thermo Scientific) and sliced into 10-μm sections by cryostat 351 microtome (Leica CM3050 S). The cryosections were incubated in antigen retrieval 12 solution at 70°C for 20 min and then incubated in 1% BSA for 2 h. After BSA blocking, 353 the cryosections were subjected to immunofluorescence staining with anti-TUJ1 and 354 anti-GFAP antibodies, followed by incubating with fluoresce-conjugated secondary 355 antibodies. DAPI is used to stain the nuclei at room temperature for 10 min. Finally, the 356 cryosections were mounted by using 90% glycerol. Fluorescence images of brain Asymmetry use of forelimb was measured to represent functional recovery of damaged 371 brain region. To this end, the cylinder test was conducted on 1 day before injury (-1 dpi, 372 day post injury), and 1-3 dpi, during 7-9 pm to quantify the asymmetry use of forelimbs. 373
The timeline of the experimental design is depicted below. 2002). Briefly, C57BL/6 mice were put in a transparent cylinder of plexiglass and the 377 behavior was recorded. The number of times that the forelimbs contact on the cylinder 378 wall was calculated in 5 minutes. Valid forelimb-wall contacts were considered for 379 further data quantification if the forelimbs were raised over the shoulder of the mice. 380 13 Data of cylinder test are quantified by calculating the percentage of the unimpaired left 381 forelimb use (ipsilateral limb to the CCI site) which was calculated by following 382 parameter: (1) the frequency of the mice using its left forelimb first (U, unimpaired) (2) 383 the frequency of the mice using its right forelimb first (I, impaired) (3) the frequency 384 of the mice using both forelimbs (B, both). The percentage of the unimpaired limb use 385 was calculated as [U / (U+I+B)], indicated as "% left forelimb use". To minimize bias, 386 data collected from behavior experiments of sham group animals demonstrating slight 387 brain injury or CCI animals failed to be injured at expected brain regions were excluded, 388 according to immunostaining of the cryosections. Among available behavior recordings, 389 only data where forelimb contact equals to or more than three times in the given 390 duration were included. To evaluate neuronal regeneration, rat cortical neurons were cultured in vitro. On DIV8, 405 primary cortical neurons were injured by scraping lines through the culture with a p20 406 tip ( Fig. 1a ). It was estimated that 10% neurons were injured via this approach. An anti-407 mitotic reagent, AraC, was added to the culture medium to inhibit proliferation of glial 408 WNTs) cortical neurons ( Fig. 2a-b ). There were 12 out of 19 WNT genes were up-425 regulated in 1-2 fold in response to injury on both iDIV9 and iDIV10. A pathway-426 focused superarray analysis of 88 WNTs and WNT target genes showed that 48 genes 427 (54.5%) were up-regulated. Among them, WNT3, WNT3A, WNT4, WNT5A, WNT5B, 428 WNT6, WNT7A, WNT8A, WNT8B, WNT9A, WNT9B and WNT10B expression were up-429 regulated (fold change > 1.5) during regeneration (Fig. 2c ). Increased expression of 430 WNT3A, WNT8A, WNT9B on iDIV10 compared to DIV10 was validated by qPCR, with 431 the expression of WNT3A and WNT9B showing significant increase (Fig. 2d) . Although 432 the fold increase of WNT genes is not high, local concentration of secreted WNTs in the 433 15 brain tissue under tight control of blood-brain-barrier (BBB) may be sufficient to trigger 434 cellular response. To address the effect of WNT proteins on the regeneration of injured cortical neurons 439 directly, WNT3A, WNT8A, WNT9B, and WNT10A recombinant proteins were added. 440
The percentage of relative regeneration was determined as average distance of neurite 441 re-growth compared to the initial width of the injury gap. As shown in Fig. 3a-b , the 442 regeneration of injured cortical neurons was improved by 20-25% in the presence of 443 WNT3A compared to without WNT3A by 72 h (iDIV11). The addition of WNT8A, 444 WNT9B, and WNT10A also enhanced regeneration of injured cortical neurons, though 445 not to the same extent as WNT3A did (Fig. 3a) . 446
Thus, the WNT3A-dependent regeneration was further examined by treating injured 447 cortical neurons with IWR-1, a WNT3A inhibitor, and neuronal regeneration was 448 inhibited (Fig. 3c) . To assess the effect of WNT3A in a multicellular three-dimensional 449 (3D) culture, organotypic brain slice culture was used. Brain slices were injured in the 450 olfactory tubercle, followed by WNT3A or PBS treatment. In order to reduce injury-451 induced glial cell proliferation, which has been shown to hinder neurite re-growth, 452 effect of combining WNT3A+AraC or PBS+AraC was also compared. As shown in Fig.  453 3e-f, injured brain slice treated with WNT3A significantly increased the length of to that of sham-treated group, whereas there was no significant difference between 471 sham-treated group and WNT3A-treated group (Fig. 4b, middle and right panels). There 472 was also no difference between PBS-treated and WNT3A-treated groups. This result 473 suggests that WNT3A administration does not reduce injury-induced proliferation of 474 glial cells. Functional recovery of damaged motor and somatosensory brain regions was 475 assessed by cylinder test conducted on 1 day before injury (-1 dpi), 1, and 3 dpi to 476 quantify the asymmetry use of forelimb. If left brain was injured, motor function of the 477 right forelimb would be impaired. A preferred usage of left forelimb (asymmetry use) 478 would be observed. As revealed in Fig. 4c , sham-treated mice exhibited 10% variation 479 of asymmetry score from 1-3 dpi compared to that of -1 dpi. PBS administration 480 increased 20-25% asymmetry score from 1-3 dpi compared to that of -1 dpi, reflecting 481 obvious brain injury. WNT3A administration reduced asymmetry score 10% on 1 dpi 482 and increased 5% on 3 dpi. These results suggest that WNT3A may protect neurons or 483 promote neuronal regeneration during the first three days after TBI. 484 485
Putative enhancer region for WNT3A expression 486
To investigate the mechanism by which injury-induced WNTs expression is regulated, 487
we had performed ChIP-seq analysis of histone H3K4me3 and H3K27ac modifications. 488
The normalized H3K4me3 ChIP-seq profiles of WNT-related genes were aggregated 489 across ± 4 kb promoter regions with TSSs as the anchors (Fig. 5a ). The aggregated 490
ChIP-seq signals aligned to the proximal promoters of WNT-related genes were 491 increased up to 1.6-fold on iDIV10 compared to DIV10. ChIP-qPCR analyses for 492
H3K4me3 at promoters of WNTs were then performed. As shown in Fig. 5b , active 493
H3K4me3 mark at the gene promoter of WNT10A was increased, whereas those for 494 WNT3A and WNT9B were not. If the transcriptional regulation of WNT3A and WNT9B 495 was not through promoter, it might be regulated by a distal enhancer. 496
To test this suggestion, a number of computational tools have been employed to 497 predict candidate enhancers during regeneration of injured cortical neurons. For 498 example, ChromHMM, an approach for chromatin-state discovery and characterization 499 (Ernst & Kellis 2012), identified candidate enhancer regions based on extracting 500 general chromatin features of enhancers. We classified the rat genome into 10 states, 501 according to histone codes and the occupancy of transcription factors (Fig. 5c ). To do 502 so, we utilized our reference datasets of H3K4me3, H3K27ac, Krüppel-like factor 4 503 (KLF4) and Krüppel-like factor 7 (KLF7) ChIP-seq profiles, as well as published ChIP-504 seq datasets of H3K9me3, RNA polymerase II (RNAPII), Sox10, and H3K27ac from 505 the GEO (GSE41217, GSE22878, GSE64703, GSE63103, and GSE64971) of multiple 506 cell types in the nervous system for training chromatin-state models. Sites with highly 507 enriched H3K27ac marks (active enhancers) and no occupancy of RNAPII (Fig. 5c,  508 upper panel) that are distal to the TSS (Fig. 5c, bottom panel) in genomic regions, 509 annotated as State2, are likely to represent enhancer regions (Fig. 5c ). We then defined 510 ten genomic regions within a 1.8-Mb interval flanking the WNT3A TSS in the rat 511 genome (RCSC 6.0/rn6). These regions, e1 to e10, represented putative enhancer 512 domains that may regulate the expression of WNT3A genes. Each predicted domain 513 contains a high density of State2 genomic elements assigned by ChromHMM (Fig. 5d) . 514
Notably, this 1.8-Mb region also includes the WNT9A gene, and it is possible that 515 WNT3A and WNT9A share common enhancers for coordinated transcriptional control. 516
To screen the enhancer regions that are active during neuronal regeneration, H3K27ac 517
ChIP-seq signals were evaluated. As shown in Fig. 5e , H3K27ac signals mapped to 518 each putative enhancer domain were aggregated. The ChIP-seq signal density for 519
H3K27ac was elevated at the e2, e5, e7, e10 enhancer regions in iDIV10 samples 520 compared to DIV10. The H3K27ac modification in e1 and e8 were slightly increased, 521
whereas no obvious change could be observed in e3, e4, e6, and e9 regions. In contrast, 522
H3K27ac modification in e1-e10 was generally decreased or remained unchanged 523 throughout the enhancer regions on iDIV9 compared to DIV9. Thus, the candidate 524 enhancer for induced WNT3A expression may lie within e2, 5, 7 and 10. 525
While the predicted enhancers for the WNT3A gene reside within the region from 526 +100 kb to -1 Mb to the TSS (e1-e10), it is reasonable to speculate that the regulation 527 of WNT3A expression is governed by spatial chromatin interaction between functional 528 genomic elements, for instance, promoter-enhancer interaction. To investigate possible 529 interactions between WNT3A promoter and the putative enhancers, significant 530 interactions around WNT3A gene promoter were identified by the 3D Interaction 531
Viewer and database (3DIV) online tool (https://www.kobic.kr/3div/). 3DIV collected 532 18 publicly available Hi-C data in human cell/tissue types and provides normalized 533 chromatin frequencies as well as browsing visualization tool for scientists to further 534 interpret genome-wide chromatin interactions (Yang et al. 2018) . As shown in Fig. 6a , 535 several topologically associating domains (TADs) were identified within an interaction 536 range of 2 Mb around WNT3A in the genome of human hippocampal tissue (Schmitt et 537 al. 2016 ). The genomic region homologous to the e2 enhancer in the rat genome resides 538 within one of the TADs that comprises WNT3A gene and presents relatively high 539 interaction frequency to WNT3A. Moreover, according to the GeneHancer database, an 540 integrated human enhancer database that infers enhancer-gene associations (Fishilevich 541 et al. 2017) , also suggests a high likelihood score of this region as potential elite 542 promoter/enhancer for WNT3A gene (GeneHancer score: 2.5; Gene Association Score: 543 10.6; Total score: 25.53). The relative position of e2 to WNT3A is similar between 544 human and rat, with the TSS distance of +79.5 kb and +57.8 kb to the e2 region, 545 respectively. Through mapping the homologous loci of rat e5-e7 region to the human 546 genome, a serendipitous finding revealed an evolutionary shift of e5-e7 region to a 547 different chromosome in human (chromosome 17), different from e2 region and 548 WNT3A gene (chromosome 1). Nonetheless, the homologous e5 and e7 regions reside 549 within two separated TADs and the data suggests an interaction between e5 and e7 ( Fig.  550   6b) . This finding uncovers a possibility of long-range inter-chromosomal regulation of 551 WNT3A gene in human. 552
To determine whether these putative enhancer regions contain enhancer signature, 553
we compared several enhancer-specific histone marks. While there is currently no 554 publicly accessible ChIP-seq database for rat brain, we compared ChIP-seq datasets for 555
H3K27ac and H3K4me1 enhancer marks in mouse forebrain that are available in the 556 ENCODE database (https://www.encodeproject.org/) (Rosenbloom et al. 2013) . 557
Homologous enhancer regions between rat and mouse were identified, and the 558 annotations of putative enhancer domains in the rat genome were converted to the 559 mouse genome (Casper et al. 2018; Kent et al. 2002) . ENCODE annotation data for the 560 homologous regions is shown in Fig. 6c . Overlapping enhancer marks were found 561 within homologous enhancer domains, with a clear decrease of the H3K4me1 mark in 562 these regions from E16.5 to postnatal day 0 (P0), according to ChIP-seq. For example, 563 normalized signal of H3K4me1 mark in the e5-e6 regions reduced around 3 folds (from 564 20.4 to 6.9) during development while around 2 folds (from 7.1 to 14.5) decrease in the 565 19 e7 regions ( Fig. 6c , indicated in the red boxes); however, the level of H3K27ac mark 566 remained relatively constant over the same time period. This differential decrease of 567 histone modification suggests that the H3K4me1 may prime and activate enhancers 568 during development and thus could be a cue for RAG regulation during neuronal 569 regeneration. The existence of CTCF sites surrounding e1-e2, e4, e5-e6, and e7-e10 570 regions probably reflects a functional role of the CTCF architectural protein in bridging 571 enhancer-promoter interacting topology (Ong & Corces 2014; Ren et al. 2017) (Fig. 6c) . 572
To examine the role of the H3K4me1 modification at putative enhancers of WNT3A, 573
ChIP assays of H3K4me1 modification at the e5, e7, e10 were performed before and 574 after injury. As shown in Fig. 7a -c, the H3K4me1 modification at e5 sub-regions, e5-1, 575 e5-2, and e5-3, significantly increased on iDIV9 and iDIV10 compared to uninjured 576 controls. Similarly, the H3K4me1 mark at e7 sub-region, e7-3, significantly increased 577 during regeneration (Fig. 7a, d-e ). H3K4me1 modification at e10 was not detectable via 578 qPCR. Notably, given that recent studies have linked the expression of non-coding 579 enhancer RNAs (eRNAs) to functional enhancers (Ding et al. 2018; Zhu et al. 2013; 580 Meng & Bartholomew 2018), the expression of cognate eRNA derived from the e5 and 581 e7 were also examined. As shown in Fig. 7f -g, the relative expression of e5-3, e7-4, e7-582 5 eRNA significantly increased on iDIV9. Expression of MPRIP and RAI1 genes, 583 located within the e5 and e7 regions respectively, did not change during regeneration 584 (data not shown). These results suggest that the H3K4me1-modulated e5/e7 region may 585 be an active enhancer for WNT3A during regeneration. 586
Together, we propose that the distal enhancer e5 (chr10: 46,023,200-46,097,800) 587 and e7 (chr10: 46,518,000-46,553,800) regions, containing H3K4me1-marked TAD, 588 are spatially brought together to enhance the transcription of eRNAs. These eRNAs 589 may recruit transcriptional components allowing e5/e7 enhancer-promoter looping to 590 coordinate WNT3A gene expression. Alternatively, the downstream e2 region (chr10: 591 45,565,000-45,580,200) loops to interact with promoter of WNT3A and induces its 592 expression ( Fig. 7h ). In the last decade, researchers have gained understanding of the H3K4me1-primed enhancer activation (Fig. 5e ). Histone ChIP-qPCR assays 615 demonstrated that H3K4me1 at the e5 region was increased as early as iDIV9, 616 concomitant with increased eRNA transcripts (Fig. 7b, f) . Moreover, the variable 617 patterns and limited increase of H3K27ac at the e5 and e7 enhancer on iDIV10 found 618 in the ChIP-seq support a dominant role of H3K4me1 in the transcriptional activity of 619 e5/e7 under the context of neuronal regeneration (Fig. 5e ). While H3K4me1 marks 620 primed/active enhancer collaboratively with other histone modifications (such as 621
H3K27ac for active enhancer) and has played a decisive role in enhancer activation, the 622 cellular mechanism leads to transcriptional changes is under-studied ( 
